ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023
Erratum: Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.